Scinai Immunotherapeutics (SCNI) Long-Term Deferred Tax (2024 - 2025)

Scinai Immunotherapeutics (SCNI) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $28.1 million as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 20.04% to $28.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.1 million through Dec 2025, up 20.04% year-over-year, with the annual reading at $28.1 million for FY2025, 20.04% up from the prior year.
  • Long-Term Deferred Tax hit $28.1 million in Q4 2025 for Scinai Immunotherapeutics, up from $23.4 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $28.1 million in Q4 2025 to a low of $23.4 million in Q4 2024.